Stem Cells http://www.stemcellsportal.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patchen, M.L.
Right arrow Articles by Quesenberry, P.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patchen, M.L.
Right arrow Articles by Quesenberry, P.J.
Stem Cells, Vol. 16, No. 3, 208-217, May 1998
© 1998 AlphaMed Press

Mobilization of Peripheral Blood Progenitor Cells by Betafectin® PGG-Glucan Alone and in Combination with Granulocyte Colony-Stimulating Factor

M.L. Patchen, J. Liang, T. Vaudrain, T. Martin, D. Melican, S. Zhonga, M. Stewarta, P.J. Quesenberrya

Alpha-Beta Technology, Inc., Worcester, Massachusetts, USA and
a The University of Massachusetts Cancer Center, Worcester, Massachusetts, USA

Key Words. Hematopoiesis • Peripheral blood progenitor cells • Mobilization • Reconstitution • Radioprotection • Chemokines • PGG-Glucan • Betafectin® • G-CSF

Dr. Myra L. Patchen, Preclinical Pharmacology, Alpha-Beta Technology, Inc., One Innovation Drive, Worcester, MA 01605 USA.

Betafectin® PGG-Glucan, a novel ß-(1,6) branched ß-(1,3) glucan purified from the cell walls of Saccharomyces cerevisiae, has been shown to synergize with myeloid growth factors in vitro and to enhance hematopoietic recovery in myelosuppressed mice and primates. Here we report that PGG-Glucan is also capable of mobilizing peripheral blood progenitor cells (PBPC). PGG-Glucan (0.5 mg/kg to 16 mg/kg) was administered intravenously to C3H/HeN male mice and blood collected at times ranging from 30 min to seven days after injection. Based on granulocyte-macrophage colony-forming cell (GM-CFC) levels, peak mobilization occurred 30 min after a 2 mg/kg PGG-Glucan dose. At this time GM-CFC numbers in PGG-Glucan-treated mice were approximately fourfold greater than in saline-treated control mice. A second, smaller wave of GM-CFC mobilization (approximately twofold increase) also occurred on days 4 and 5 after PGG-Glucan treatment. Mobilization was not associated with the induction of {alpha}-chemokines, which have recently been reported to induce rapid progenitor cell mobilization. Competitive repopulation experiments performed in irradiated female C3H/HeN mice revealed that, at three months after transplantation, more male DNA was present in bone marrow, splenic, and thymic tissues from animals transplanted with cells obtained from mice 30 min after a 2 mg/kg PGG-Glucan dose than in tissues from animals transplanted with cells obtained from saline-treated mice. Additional experiments evaluated the mobilization effects of PGG-Glucan (2 mg/kg) administered to mice which had been pretreated for three consecutive days with G-CSF (125 µg/kg/day). When blood was collected 30 min after PGG-Glucan treatment, the number of GM-CFC mobilized in combination-treated mice was additive between the number mobilized in mice treated with G-CSF alone and the number mobilized in mice treated with PGG-Glucan alone. These studies demonstrate that: A) PGG-Glucan can rapidly mobilize PBPC; B) the kinetic pattern of PGG-Glucan-induced mobilization is different from that of the CSFs; C) the reconstitutional potential of PGG-Glucan mobilized cells is greater than that of steady-state PBPC, and D) PGG-Glucan can enhance G-CSF-mediated PBPC mobilization.




This article has been cited by other articles:


Home page
Stem CellsHome page
D. E. Cramer, S. Wagner, B. Li, J. Liu, R. Hansen, R. Reca, W. Wu, E. Z. Surma, D. A. Laber, M. Z. Ratajczak, et al.
Mobilization of Hematopoietic Progenitor Cells by Yeast-Derived {beta}-Glucan Requires Activation of Matrix Metalloproteinase-9
Stem Cells, May 1, 2008; 26(5): 1231 - 1240.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
H. Lin, S. W. Y. Cheung, M. Nesin, B. R. Cassileth, and S. Cunningham-Rundles
Enhancement of Umbilical Cord Blood Cell Hematopoiesis by Maitake Beta-Glucan Is Mediated by Granulocyte Colony-Stimulating Factor Production
Clin. Vaccine Immunol., January 1, 2007; 14(1): 21 - 27.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
B. W. LeBlanc, J. E. Albina, and J. S. Reichner
The effect of PGG-{beta}-glucan on neutrophil chemotaxis in vivo
J. Leukoc. Biol., April 1, 2006; 79(4): 667 - 675.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. A. Sweeney, G. V. Priestley, B. Nakamoto, R. G. Collins, A. L. Beaudet, and T. Papayannopoulou
Mobilization of stem/progenitor cells by sulfated polysaccharides does not require selectin presence
PNAS, June 6, 2000; 97(12): 6544 - 6549.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 1998 by AlphaMed Press.